Establishment Labs Holdings ESTA
NASDAQ ESTA
$74.69 -0.60 (-0.80%)
As of: Sep 9, 2026 · 12:11 PM EDT

Establishment Labs Holdings (ESTA) Net Income towards Common Stockholders (2017 - 2026)

Establishment Labs Holdings (ESTA) posted Net Income towards Common Stockholders of -$11.7 million for Q2 2026, up 12.21% on a QoQ basis from -$13.4 million in Q1 2026, and up 29.2% year-over-year from -$9.1 million in Q2 2025.

Analysis

Establishment Labs Holdings (ESTA) Net Income towards Common Stockholders (2017 - 2026) Analysis & Trends

Establishment Labs Holdings has reported Net Income towards Common Stockholders for 10 years, with the latest figure at -$11.7 million in Q2 2026.

  • On a quarterly basis, Net Income towards Common Stockholders rose 29.2% year-over-year to -$11.7 million in Q2 2026; TTM through Jun 2026 was -$38.9 million, a 56.06% increase from a year earlier, with the FY2025 full-year figure at -$51.1 million, up 39.64% from the prior year.
  • Net Income towards Common Stockholders was -$11.7 million for Q2 2026 at Establishment Labs Holdings, up from -$13.4 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$2.6 million in Q4 2025, with the low at -$37.1 million in Q2 2022.
  • Average Net Income towards Common Stockholders over 5 years is -$17.5 million, with a median of -$16.6 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders plunged 597.22% in 2022, then surged 92.43% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at -$13.6 million in 2022, then sank by 51.47% to -$20.5 million in 2023, then slumped by 68.1% to -$34.5 million in 2024, then soared by 92.43% to -$2.6 million in 2025, then slumped by 349.25% to -$11.7 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$11.7 million (Q2 2026), -$13.4 million (Q1 2026), and -$2.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 184.10 Bn 178.50 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 124.21 Bn 118.99 Bn 1.96 Bn 823.20 Mn
3 Medtronic 118.33 Bn 109.51 Bn 6.34 Bn 1.48 Bn
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.39 Bn 65.86 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.69 Bn 45.43 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.94 Bn 32.48 Bn 1.68 Bn -
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn 249.10 Mn
9 Steris 21.15 Bn 20.67 Bn 684.20 Mn 201.00 Mn
10 Establishment Labs Holdings 2.25 Bn 2.18 Bn 47.71 Mn -11.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.75 Mn
Mar 31, 2026 -13.38 Mn
Dec 31, 2025 -2.62 Mn
Sep 30, 2025 -11.15 Mn
Jun 30, 2025 -16.59 Mn
Mar 31, 2025 -20.71 Mn
Dec 31, 2024 -34.53 Mn
Sep 30, 2024 -16.68 Mn
Jun 30, 2024 -17.18 Mn
Mar 31, 2024 -16.20 Mn
Dec 31, 2023 -20.54 Mn
Sep 30, 2023 -29.27 Mn
Jun 30, 2023 -16.75 Mn
Mar 31, 2023 -11.94 Mn
Dec 31, 2022 -13.56 Mn
Sep 30, 2022 -18.61 Mn
Jun 30, 2022 -37.11 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -14.19 Mn
Sep 30, 2021 -14.68 Mn